Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000173138 | SCV000224227 | likely benign | not specified | 2015-06-04 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000369522 | SCV000402435 | likely benign | Renal cysts and diabetes syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
SIB Swiss Institute of Bioinformatics | RCV000369522 | SCV000803619 | uncertain significance | Renal cysts and diabetes syndrome | 2018-05-31 | criteria provided, single submitter | curation | This variant is interpreted as a Uncertain Significance - Conflicting Evidence, for Renal cysts and diabetes syndrome, in Autosomal Dominant manner. The following ACMG Tag(s) were applied: BS1 => Allele frequency is greater than expected for disorder (PMID:23539225). PP3 => Multiple lines of computational evidence support a deleterious effect on the gene or gene product. |
Institute of Human Genetics, |
RCV000369522 | SCV000926175 | uncertain significance | Renal cysts and diabetes syndrome | 2019-07-06 | criteria provided, single submitter | literature only | |
Athena Diagnostics | RCV000993276 | SCV001146113 | likely benign | not provided | 2018-11-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000993276 | SCV002421538 | likely benign | not provided | 2024-01-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000993276 | SCV002552723 | uncertain significance | not provided | 2022-03-16 | criteria provided, single submitter | clinical testing | Identified in multiple patients with structural renal abnormalities, however, family segregation studies have been limited, functional studies have not been performed, and only the HNF1B gene was sequenced in most publications (Ulinski et al., 2006; Nakayama et al., 2010; Musetti et al., 2014, Raaijmakers et al., 2015; Okorn et al., 2019); Identified in an individual with maturity-onset diabetes of the young, however, additional clinical and segregation information was not provided (Bellanne-Chatelot et al., 2005); Identified in randomly selected individuals from the Framingham and Jackson Heart Studies (Flannick et al., 2013); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 21775974, 24097065, 24387224, 20155289, 26764160, 25500806, 16249435, 30666461, 16371430, 31365591, 34426522, 33324081) |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000173138 | SCV003934525 | likely benign | not specified | 2023-05-22 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003316074 | SCV004015773 | likely benign | Nonpapillary renal cell carcinoma | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Sydney Genome Diagnostics, |
RCV001328309 | SCV001449332 | likely benign | Congenital anomaly of kidney and urinary tract | 2018-10-25 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000173138 | SCV002033909 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000993276 | SCV002036456 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003947459 | SCV004760606 | likely benign | HNF1B-related disorder | 2020-01-29 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |